Calcif Tissue Int (1987) 40:315-317

## Calcified Tissue International
ï¿½9 1987 Springer-Verlag New York Inc.

# The Effect of Fluoride and Calcium on Spinal Bone Mineral Content: A Controlled, Prospective (3 Years) Study

Tommy Hansson t and Bengt Roos 2

~Department of Orthopaedic Surgery I, Sahlgren's Hospital, University of Gothenburg, S-413 45 Gothenburg, Sweden; and
2Department of Radiophysics, Sahlgren's Hospital, University of Gothenburg, Sweden

### Summary. Daily treatment with 30 mg of sodium examined the effect of lower doses of fluoride in
fluoride (NaF) and 1 g of calcium over a 3-year pe- women with idiopathic osteoporosis [5].
riod increased the bone mineral content (BMC) in
the spines of women (n = 25) with osteoporosis. **Materials and Methods**
Determination of the BMC was followed with dual
photon absorptiometry (137Cs-241Am) in the third Women (n = 100) selected for this study had at least one and a
lumbar vertebra. No increase in BMC was found maximum of three vertebral compression fractures within the
with only 10 mg sodium fluoride in combination thoracic or lumbar spines, sustained during minor traumas.

Since L3 was the vertebral level used for determination of the

with calcium (n = 25), with calcium alone (n = 25),

spinal bone mineral, a fracture at this level excluded from the

or with placebo (n = 25). No serious side effects

study. All the women were postmenopausal, and none had

were registered. There was, however, minor gastro- known diseases or was taking a medication that could directly
intestinal distress in one-fifth of the patients taking influence the normal skeletal metabolism.
30 mg NaF daily. The mean age of the women was 66 (SD 6) years. They were

randomly placed into four different treatment groups (A, B, C,

### Key words: Absorptiometry -- Calcium -- Osteo- and D), each made up of 25 women. The mean age of the women

in each group and treatment given is presented in Table 1.

porosis -- Fluoride -- Fracture.

Fluoride was given as sodium fluoride. It was administered in
capsules containing 30 (Group A) or 10 mg each (Group B). Cal-
cium was given to both of these groups, and to another that did
not receive fluoride (Group C), as a combination of bicarbonate,
lactate, and gluconate, 1 g/day. The patients in group D got one

Fluoride has been given to humans based on the daily capsule containing placebo (starch). The patients receiving

fluoride took it in the morning and the calcium in the evening.

hypothesis that it stimulates formation of new bone

Roentgenograms of the lumbar and thoracic spines were taken

which is normally mineralized if sufficient calcium

within 1 month after the treatment started and again after three

is provided. Most (60-70%) osteoporotic women years of treatment. The changes in the BMC of the third lumbar
respond to fluoride without side effects and studies vertebra (L3) were followed with dual photon absorptiometry
have shown an increase of bone mass (up to [12, 13]. BMC was determined at the start of the treatment, at 1
30-50% in 1 year) and a tenfold decrease of frac- year, 11/2 years, 2 years, and 3 years of treatment. Our dual
tures [1-9]. However, these studies have used high photon absorptiometer uses two radionuclides with different

gamma energies (241Americium and 137Cesium) arranged so there

doses of NaF (50-80 mg/day), which induce signifi-

is a common collimated radiation beam. The transmitted radia-

cant side effects, and have not included control

tion of both energies is measured with a scintillation detector

groups. Since we, in an earlier trial, found the same and nuclear counting instrumentation. The radiation beam is
effect on the BMC of the spine after medication centered over the L3 using an X-ray tube and an image intensi-
with 50 mg NaF as with 30 mg NaF daily, this study fier. Transmission measurements are then performed as a scan-

ning procedure over the vertebra in 4 mm steps. By plotting the
attenuated energies at each step, a bone profile curve is obtained
from which the BMC is calculated. The stability of the absorpti-

_Send reprint requests to Dr. Tommy Hansson and the above ad-_ ometer, which is of crucial importance for a high reproducibility
dress. especially in a study extended over several years, has **been**


-----

316 T. Hansson and B. Roos: Effect of Fluoride and Calcium on Spinal BMC

Table 1. Changes in osteoporotic women of BMC (g/cm) in L3 BMC g/cm BMC g/cm
over 3 years treatment 3.6

Treatment Year
Group Age NaF Ca 0 1.0 1.5 2.0 3.0 3.5

A 65.2 30 1 2.72 2.94 2.97 3.09 a 3.18 b

3.4

B 66.4 10 1 2.75 2.77 2.78 2.75 2.83
C 64.6 0 1 2.69 2.68 2.74 2.74 2.68
D 67.2 placebo 2.75 2.81 2.73 2.72 2.67 3.3

Comparisons were made with the initial BMC value

3.2

a p < .05
b p < .01

3.1

tested by 57 measurements of the same Al-phantom over a pe- 3.0
riod of 5 years. The 57 measurements gave a regression line with
a slope that differed 0.15% from a straight line [10]. The accu-

2.9

racy of our method has been determined in numerous vertebrae
before and after they have been ashed. The accuracy has also
been determined by measurements first of vertebrae _in situ_ in 2.8
the body and then after they have been excised from the body. In
these experiments the errors in accuracy and reproducibility

2.7

have been found to be less than 3% [10-12]. A more detailed
description of the theory and the measuring technique has been
given earlier [11, 12]. 2.6

2.5

**Results**

2.4

### The BMC changes in the four different groups are

Start of 3 yrs

### presented in Table 1. treatment
 The number of patients who completed the 3-

**Fig.** 1. The individual changes in BMC in group A during 3

### year study were 24 in Group A, 23 in Group B, 22 years' treatment with 30 mg NaF and calcium. The dotted lines in Group C, and 19 in Group D. There were no sta- represent the 5 subjects who did not respond to this treatment. tistically significant changes in the BMC in groups B, C, or D. Group A increased significantly (P < 0.01). The absolute increase in BMC in Group A
 of women; two occurred in Group B and one in
 was 0.46 g/cm, which corresponded to a 17% in-
 Groups C and D respectively.
 crease over the 3 years of treatment.
 The increase of BMC in Group A was statisti- cally significant after 11/2 years of treatment, with a majority of the women showing an increase. After 3 Discussion years, 19/25 showed an increase, 5/25 showed a de- crease. The biggest individual increase over 3 years This controlled, prospective study indicated that 30 was 27.1%, while the biggest individual decrease mg of sodium fluoride and 1 g calcium taken daily was 4.2%. The mean increase among the re- significantly increased the BMC in the lumbar sponders in Group A was 18.5%. The corre- spine. The average value after 3 years of treatment sponding decrease among the nonresponders in the among the women in group A was in the lower por- same group was 2.2%. The individual changes in tion of the normal range for age-matched normals. Group A are shown graphically in Figure 1. Five of This increase was not found when only 10 mg so- the patients in Group A had adverse reactions prob- dium fluoride or only calcium was given daily. ably caused by the treatment. Four had mild gastro- Pending that the increase of BMC reflected an ap- intestinal symptoms (nausea and gastritis). One pa- position of bone with normal qualities, the increase tient developed a peptic ulcer which forced her to of BMC in those 76% who did respond in Group A abandon the treatment after 10 months. Two of the probably could be of a sufficient magnitude (18.5%) women with adverse reactions belonged to the to lower the risk of new fractures due to minor nonresponders. Four certainly new vertebral com- traumas. In another study [14] we found that a pression fractures were noticed in the entire group BMC deficit of about 15-20% was associated with


-----

T. Hansson and B. Roos: Effect of Fluoride and Calcium on Spinal BMC 317

an apparent risk of the first vertebral fracture in 2. Briancon D, Meunier PJ (1980) Le fluor en pathologie et en
women of this age; fluoride treatment over only 3 thrrapeutic osseuses: son application au traitement des os-

troporoses. Lyon Med 243:183-94

years put a majority of the responding subjects

3. Christiansen C, Christiansen MS, McNair P, Hagen C,

above this threshold.

Stocklund KE, Transboel I (1980) Prevention of early post-

A lower incidence of compression fractures after menopausal bone loss. Eur J Clin Invest 10:273-279
fluoride/calcium treatment has been reported from 4. Franke J 1978 Our experience in the treatment of osteo-

studies in osteoporotic patients [2, 4, 10]. As in porosis with relatively low sodium fluoride doses. In: Cour-
these earlier studies, however, not all individuals voisier B, Donath A, Baud CA (eds) Fluoride and bone.

Hans Huber Publishers, Bern, Switzerland, pp 238-241

respond to fluoride treatment and there are some

5. Hansson T, Roos B. (1978) Osteoporoses. Effect of com-

mildly adverse side effects even at low doses. The

bined therapy with sodium fluoride, calcium and vitamin D

lack of response may reflect lack of bone cell ac-

on the lumbar spine in osteoporosis. AJR 126:1294-1297

tivity, an absence of precursor bone cells, or a 6. Jowsey J, Riggs BL, Kelly PJ, Hoffman DL (1972) Effect of
simple failure to elevate blood fluoride levels (pos- combined therapy with sodium fluoride, vitamin D and cal-
sibly associated with noncompliance in those with cium in osteoporosis. Am J Med 53:43-49
side effects). Some studies [2, 3] have failed to 7. Reutter FW, Olah AJ (1978) Bone biopsy findings and clin-

ical observations in long-term treatment of osteoporosis

show positive responses to fluoride on the predomi-

with sodium fluoride and vitamin D. In: Courvoisier B,

nantly compact bone (75%-95%) of the distal

Donath A, Baud CA (eds) Fluoride and bone. Hans Huber

radius (even in patients who responded vigorously

Publishers, Bern, Switzerland, pp 249-255

in iliac crest biopsy [2]), but this discrepancy from 8. Riggs BL, Hodgson SF, Hoffman DL, Kelly PJ, Johnson
our results could be explained, for example, by a KA, Taves D (1980) Treatment of primary osteoporosis with
difference in effectiveness of this agent on trabec- fluoride and calcium. JAMA 243:446-449
ular bone of the axial skeleton. As with previous 9. Riggs BL, Seeman E, Hodgson SF, Taves DR, O'Fallon

WM (1982) Effect of the fluoride/calcium regimen on verte-

studies on compact bone, however, no effect of cal-

bral fracture occurrence in postmenopausal osteoporosis. N

cium supplementation was evident in the spine.

Engl J Med 306:446-450

Given the normal calcium intake of Swedish pa- 10. Ringe JD, Kruse HP, Kuhlencordt F (1978) Ergebnisse einer
tients (about 800 mg/day), it is not clear if the cal- Langzeittherapie der primfiren Osteoporose mit Natrium-
cium provided with the fluoride therapy is neces- fluorid. Dtsch Med Wochenschr 103:248-252
sary in this population, thought it may be of value 11. Roos BO, Skrldborn H (1974) Dual photon absorptiometry

in lumbar vertebrae. I. Theory and method. Acta Radiol

in the populations where a lower dietary intake

3:266-280

provides insufficient mineralization resources for

12. Roos BO (1975) Dual photon absorptiometry in lumbar ver-

the fluoride-induced bone.

tebrae. II. Precision and reproducibility. Acta Radiol 3:291-
303

### Acknowledgments. The study was supported by the Swedish 13. Roos B, Hansson T (1980) Dual photon absorptiometry in
Medical Research Council (17X-6576) and Asker's Foundation. lumbar vertebrae. An experimental study of the baseline

error. Acta Radiol 19:111-114
t4. Hansson T, Roos B (in press) The bone mineral content of

**References** the lumbar spine at the occurrence of the first vertebral

crush fracture. Clin Orthop

1. Baylink DJ, Bernstein DS (1967) The effects of fluoride

therapy on metabolic bone disease: a histologic study. Clin
Orthop 55:51-85 Received March 27, 1986, and in revised form October 31, 1986.


-----

